QPTFF.US Quest PharmaTech Inc

Healthcare Biotechnology USA Stocks
0.0300 USD
Close of Nov 17, 2026
0.0133 0.0310
Market cap
USD 5.07M
P/E
1.5x
P/B
0.27x
ROE
2.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jul 2026.

Is QPTFF.US undervalued?

Graham number

The Graham number of Quest PharmaTech Inc cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Quest PharmaTech Inc fundamental analysis

No fundamental analysis for Quest PharmaTech Inc yet.

Quest PharmaTech Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Quest PharmaTech Inc

Quest PharmaTech Inc., a pharmaceutical company, develops targeted cancer therapies in Canada. Its lead product is MAb AR9.6, a theranostic agent for cancer in preclinical development for pancreatic cancer. The company is headquartered in Edmonton, Canada.

Full company profile